← Back to Analyst Consensus 
FBIO Buy
Fortress Biotech, Inc.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 12, 2026 (17 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Feb 23, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $17 | 44% |
| Aug 21, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $17 | 44% |
| Mar 11, 2025 | Roth MKM | reiterate | Buy → Buy | $16 | 52% |
| Nov 18, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $26 | 44% |
| Jul 19, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $24 | 44% |
| Jun 20, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| May 16, 2024 | Roth MKM | reiterate | Buy → Buy | $10 | 52% |
| Mar 19, 2024 | Alliance Global Partners | initiate | — → Buy | $5 | 41% |
| Nov 29, 2023 | Roth MKM | maintain | Buy → Buy | $15 | 52% |
Price Target Trend
Mar 30, 2026 Latest: $5 Oct 24, 2026
EPS Estimates
0q $-0.27
Lo: $-0.27 Hi: $-0.27
1 analysts +1y $-1.00
Lo: $-1.00 Hi: $-1.00
1 analysts +1q $-0.25
Lo: $-0.25 Hi: $-0.25
1 analysts 0y $2.55
Lo: $2.55 Hi: $2.55
1 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days